[Trends and perspectives of psychopharmacology].
D000661:Amphetamine / Q000009:adverse effects / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D002110:Caffeine / Q000009:adverse effects / Q000627:therapeutic use; D006213:Hallucinogens / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects / Q000627:therapeutic use; D001523:Mental Disorders / Q000188:drug therapy*; D008774:Methylphenidate / Q000009:adverse effects / Q000627:therapeutic use; D011600:Psychopharmacology; D014149:Tranquilizing Agents / Q000009:adverse effects / Q000627:therapeutic use
D000928:Antidepressive Agents; D006213:Hallucinogens; D006993:Hypnotics and Sedatives; D014149:Tranquilizing Agents; D008774:Methylphenidate; D002110:Caffeine; D000661:Amphetamine
Entwicklungsrichtungen und Perspektiven der Psychopharmakotherapie.